All News

An early clinical trial participant likens his journey into the unknown to a space mission.

Searching for healthcare information online is a fact of life. Here are some ideas for how to do it responsibly.

"I don’t have cancer, but here I am. This is my life. This is my reality. I am BRCA positive."

A man who received chimeric antigen receptor-T cell therapy shares his firsthand account.

CURE spoke with an expert on how patients can better advocate for themselves when it comes to genetic testing and its follow-up.

Let music keep you company during and after cancer.

Here are the top five CURE stories for September 2019.

Although there is much to learn about the intricacies of how the immune system interacts with cancer, advances are occurring rapidly as immunotherapy for cancer has exploded with myriad ongoing clinical trials and newer drugs coming on line constantly.

Readers of CURE share the ways that cancer has changed their lives.

A male breast cancer survivor discovers that looking ahead may be good for our health.

Ovarian Cancer Research Alliance (OCRA) supports women and their families going through an ovarian cancer diagnosis, while also funding the research that will one day lead to its prevention.

The Food and Drug Administration expanded its approval of Cologuard, an at-home non-invasive colorectal cancer screening test, to include use among average-risk individuals aged 45 and older.

For Blood Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.

A two-time cancer survivor discusses her recently-discovered pancreatic cysts.

From a freezer failure that lost the stem cells of some patients with cancer to a documentary about one of the pioneers of immunotherapy, here’s what is making headlines in the cancer space this week.

Immunotherapy medications have been a wonderful addition to the arsenal of cancer therapeutics. Their use has revolutionized the treatment of many cancers and offers new hope to patients. However, these upsides do not come without downsides.

The four-drug regimen of Darzalex in combination with Velcade, Thalomid and dexamethasone has been approved for the treatment of newly diagnosed patients with multiple myeloma who are eligible for autologous stem cell transplant.

Influenza season is almost here. In an effort to prevent the spread of the viral infection, some doctors recommend an annual vaccine. In this post, one survivor shares what happened when she shared details about her breast cancer and lymphedema experience before receiving the vaccine.

Cutting-edge treatment is not out of reach, thanks to a little guidance from the Cancer Research Institute.

Topical immunotherapy may help prevent the second most common type of skin cancer in the United States, according to study findings published in JCI Insight.

Here’s a look at what’s inside our 2019 Hematology special issue.

A survivor reflects on having her breast implants removed as she hopes to turn the page in her cancer journey.

Here is a list of the recent trial initiations that occurred within the cancer space in September.

A look back at how immunotherapy began in oncology.

A recent survey found that lung cancer stigma can be a barrier to treatment; however, on the plus side, the percentage of people who associate the disease with smoking has dropped in recent years.

For some patients with melanoma, eating a diet rich in fiber could lead to an improved response to immunotherapy, according to findings presented at this year’s American Association for Cancer Research annual meeting.

October is upon us. That means much of our world can turn pink. Pink shirts, shoes, bags, jewelry, hair... I could go on. Many people buy items to support breast cancer education and research. Educating yourself as to where your money goes can be important.

CURE spoke with an expert from Mount Sinai to discuss the future of ovarian cancer treatment and his advice for women facing a new diagnosis.